Lipid-based formulations (LBFs) and softgel capsules have been shown to improve the bioavailability of poorly soluble drugs while providing a fast and cost-effective path to the clinic and market. However, fully unlocking the potential of this dosage form requires a holistic approach that seamlessly integrates formulation development and soft gel manufacturing. This webinar aims to simplify these complex scientific concepts and shed light on the nuances of LBF and softgels. Experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential